NIH-funded research R01 grant

Understanding protective factors in kidney disease for type 1 diabetes patients

Official title: Protective factors in diabetic kidney disease in patients with type 1 diabetes

Funded at Cleveland Clinic Lerner Com-Cwru · NIH-10753046 · Data updated 2026-11-12

This study is looking at how certain cells in the skin might help protect people with type 1 diabetes from kidney problems, and it hopes to find new ways to improve treatment for those at risk of diabetic kidney disease.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCleveland Clinic Lerner Com-Cwru
NIH-funded
Lab location1 site (Cleveland, United States)
Project startJanuary 1, 2023
Project endDecember 31, 2025
Funding year2023
Award (this year)$606,740
NIH project number7R01DK121019-04
Project IDNIH-10753046 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with type 1 diabetes, particularly those who have not yet developed diabetic kidney disease.

Less likely to help

Patients with type 2 diabetes or those who already have advanced diabetic kidney disease may not benefit from this research.

What this research studies

This research investigates the protective mechanisms that may help prevent diabetic kidney disease (DKD) in patients with type 1 diabetes. By examining skin fibroblasts from individuals with and without DKD, the study aims to identify unique cellular behaviors and gene expression patterns that contribute to protection against kidney damage. The researchers will analyze how these protective pathways are activated in response to high glucose levels, which can cause DNA damage. The goal is to uncover insights that could lead to improved treatments and outcomes for patients at risk of DKD.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing kidney disease in patients with type 1 diabetes.

How similar studies have gone: Previous research has indicated potential protective mechanisms in diabetic kidney disease, suggesting that this approach may yield valuable insights.

Where this research is happening

  • Cleveland Clinic Lerner Com-Cwru
    Cleveland, United States
    Active

Researchers

  • Principal investigator: Caramori, Maria Luiza a — Cleveland Clinic Lerner Com-Cwru
  • Study coordinator: Caramori, Maria Luiza a

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.